Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001032202 | SCV001195509 | pathogenic | Fumarase deficiency | 2019-02-08 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon 1 of the FH gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the FH gene. This is expected to result in an absent or disrupted protein product. Deletions of exon 1 have been reported in individuals affected with hereditary leiomyomatosis and renal cell carcinoma (PMID: 18503824, 28196407). Loss-of-function variants in FH are known to be pathogenic (PMID: 11865300, 21398687). For these reasons, this variant has been classified as Pathogenic. |